A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature

Pathology Research and Practice

Volumn 212, Issue 6, 2016, Pages 491-499

  Mignogna, Chiara ^a   Signorelli, Francesco ^a,b   Vismara, Marco Flavio Michele ^b   Zeppa, Pio ^c   Camastra, Caterina ^a   Barni, Tullio ^a   Donato, Giuseppe ^a   Di Vito, Anna ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b HÔPITAL NEUROLOGIQUE   (France)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

CD163; CD68; Glioblastoma multiforme; Immunosuppression; Macrophage polarization; Tumor associated macrophages

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; BIOTINYLATION; CANCER IMMUNOTHERAPY; CELL PLASTICITY; CELL POPULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; MACROPHAGE; MALE; MICROGLIA; POLARIZATION; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; BRAIN TUMOR; CELL POLARITY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; TUMOR MICROENVIRONMENT;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN NEOPLASMS; CELL POLARITY; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; TUMOR MICROENVIRONMENT;

EID: 84963614964     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2016.02.020     Document Type: Article

References (69)

1. [1] International Agency for Research on Cancer, World Health Organization. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., (eds.) WHO Classification of Tumors of the Central Nervous System, 4th ed., 2007, International Agency for Research on Cancer, Lyon, France, 33–49.
2. [2] Koshy, M., Villano, J.L., Dolecek, T.A., Howard, A., Mahmood, U., Chmura, S.J., Weichselbaum, R.R., McCarthy, B.J., Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J. Neurooncol. 107:1 (2012), 207–212.
3. [3] Han, K., Ren, M., Wick, W., Abrey, L., Das, A., Jin, J., Reardon, D.A., Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials. Neuro. Oncol. 16:5 (2014), 696–706.
4. [4] Frosina, G., Limited advances in therapy of glioblastoma trigger re-consideration of research policy. Crit. Rev. Oncol. Hematol. 96:2 (2015), 257–261.
5. [5] Mills, C.D., Anatomy of a discovery: m1 and m2 macrophages. Front. Immunol., 5(6), 2015, 212.
6. [6] Galluzzi, L., Vacchelli, E., Bravo-San Pedro, J.M., Buqué, A., Senovilla, L., Baracco, E.E., Bloy, N., Castoldi, F., Abastado, J.P., Agostinis, P., Apte, R.N., Aranda, F., et al. Classification of current anticancer immunotherapies. Oncotarget 5:24 (2014), 12472–12508.
7. [7] Medrek, C., Pontén, F., Jirström, K., Leandersson, K., The presence of tumor-associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12 (2012), 306–314.
8. [8] Renne, M., Conforti, F., Camastra, C., Donato, A., Donato, G., Macrophage activation and patterns of inflammation in obese and non-obese women with breast carcinoma. Eur. J. inflamm. 12:1 (2014), 197–200.
9. [9] Prosniak, M., Harshyne, L.A., Andrews, D.W., Kenyon, L.C., Bedelbaeva, K., Apanasovich, T.V., Heber-Katz, E., Curtis, M.T., Cotzia, P., Hooper, D.C., Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin. Cancer Res. 19:14 (2013), 3776–3786.
10. [10] Cai, J., Zhang, W., Yang, P., Wang, Y., Li, M., Zhang, C., Wang, Z., Hu, H., Liu, Y., Li, Q., Wen, J., Sun, B., et al. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance. Plos One, 10(5), 2015, e0126022.
11. [11] Lisi, L., Stigliano, E., Lauriola, L., Navarra, P., Dello Russo, C., Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells. ASN Neuro 6:3 (2014), 171–183.
12. [12] Collins, T.J., Image J for microscopy. BioTechniques, 2007, S25–S32.
13. [13] Badie, B., Schartner, J., Role of microglia in glioma biology. Microsc. Res. Tech. 54:2 (2001), 106–113.
14. [14] Kostianovsky, A.M., Maier, L.M., Anderson, R.C., Bruce, J.N., Anderson, D.E., Astrocytic regulation of human monocytic/microglial activation. J. Immunol. 181:8 (2008), 5425–5432.
15. [15] Kennedy, B.C., Maier, L.M., D'Amico, R., Mandigo, C.E., Fontana, E.J., Waziri, A., Assanah, M.C., Canoll, P., Anderson, R.C., Anderson, D.E., Bruce, J.M., Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunol., 10, 2009, 11.
16. [16] Morioka, T., Baba, T., Black, K.L., Streit, W.J., Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. Neurosurgery 30:6 (1992), 891–896.
17. [17] Morantz, R.A., Wood, G.W., Foster, M., Clark, M., Gollahon, K., Macrophages in experimental and human brain tumors—Part 2: studies of the macrophage content of human brain tumors. J. Neurosurg. 50:3 (1979), 305–311.
18. [18] AlShakweer, W., Alwelaie, Y., Mankung, A.M., Graeber, M.B., Bone marrow-derived microglia in pilocytic astrocytoma. Front. Biosci. (Elite Ed.) 3 (2011), 371–379.
19. [19] Kennedy, B.C., Showers, C.R., Anderson, D.E., Anderson, L., Canoll, P., Bruce, J.N., Anderson, R.C., Tumor-associated macrophages in glioma: friend or foe?. J. Oncol., 2013, 2013, 486912.
20. [20] Gordon, S., Martinez, F.O., Alternative activation of macrophages: mechanism and functions. Immunity 32:5 (2010), 593–604.
21. [21] Martinez, F.O., Sica, A., Mantovani, A., Locati, M., Macrophage activation and polarization. Front. Biosci. 13 (2008), 453–461.
22. [22] Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J., Hill, A.M., M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164 (2000), 6166–6173.
23. [23] Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:3 (2012), 787–795.
24. [24] Komohara, Y., Ohnishi, K., Kuratsu, J., Takeya, M., Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 216:1 (2008), 15–24.
25. [25] Heusinkveld, M., van der Burg, S.H., Identification and manipulation of tumor-associated macrophages in human cancers. J. Transl. Med., 9, 2011, 216.
26. [26] Pey, P., Pearce, R.K., Kalaitzakis, M.E., Griffin, W.S., Gentleman, S.M., Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease. Acta Neuropathol. Commun., 2, 2014, 21.
27. [27] Fabriek, B.O., Van Haastert, E.S., Galea, I., Polfliet, M.M., Döpp, E.D., Van Den Heuvel, M.M., Van Den Berg, T.K., De Groot, C.J., Van Der Valk, P., Dijkstra, C.D., CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 51:4 (2005), 297–305.
28. [28] Borda, J.T., Alvarez, X., Mohan, M., Hasegawa, A., Bernardino, A., Jean, S., Aye, P., Lackner, A.A., CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin–hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am. J. Pathol. 172:3 (2008), 725–737.
29. [29] Mieczkowski, J., Kocyk, M., Nauman, P., Gabrusiewicz, K., Sielska, M.G., Przanowski, P., Maleszewska, M., Rajan, W.D., Pszczolkowska, D., Tykocki, T., Grajkowska, W., Kotulska, K.M., et al. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma. Oncotarget, 2015.
30. [30] Kennedy, B.C., Maier, L.M., D'Amico, R., Mandigo, C.E., Fontana, E.J., Waziri, A., Assanah, M.C., Canoll, P., Anderson, R.C., Anderson, D.E., Bruce, J.N., Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunol., 10, 2009, 11.
31. [31] Nishie, A., Ono, M., Shono, T., Fukushi, J., Otsubo, M., Onoue, H., Ito, Y., Inamura, T., Ikezaki, K., Fukui, M., Iwaki, T., Kuwano, M., Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin. Cancer Res. 5:5 (1999), 1107–1113.
32. [32] Strojnik, T., Kavalar, R., Zajc, I., Diamandis, E.P., Oikonomopoulou, K., Lah, T.T., Prognostic impact of CD68 and kallikrein 6 in human glioma. Anticancer Res. 29:8 (2009), 3269–3279.
33. [33] Zanier, E.R., Pischiutta, F., Riganti, L., Marchesi, F., Turola, E., Fumagalli, S., Perego, C., Parotto, E., Vinci, P., Veglianese, P., D'Amico, G., Verderio, C., et al. Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics 11:3 (2014), 679–695.
34. [34] Andreeva, E.R., Pugach, I.M., Orekhov, A.N., Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis 135 (1997), 19–27.
35. [35] Lamagna, C., Aurrand-Lions, M., Imhof, B.A., Dual role of macrophage in tumor growth and angiogenesis. J. Leukoc. Biol. 80 (2006), 705–713.
36. [36] Zhao, D., Najbauer, J., Garcia, E., Metz, M.Z., Gutova, M., Glackin, C.A., Kim, S.U., Aboody, K.S., Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol. Cancer Res. 6:12 (2008), 1819–1829.
37. [37] Erler, J.T., Bennewith, K.L., Cox, T.R., Lang, G., Bird, D., Koong, A., Le, Q.T., Giaccia, A.J., Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15:1 (2009), 35–44.
38. [38] Kim, S., Takahashi, H., Lin, W.W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.L., Karin, M., Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:7225 (2009), 102–106.
39. [39] Magge, S.N., Malik, S.Z., Royo, N.C., Chen, H.I., Yu, L., Snyder, E.Y., O'Rourke, D.M., Watson, D.J., Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. J. Neurosci. Res. 87:7 (2009), 1547–1555.
40. [40] Roca, H., Varsos, Z.S., Sud, S., Craig, M.J., Ying, C., Pienta, K.J., CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J. Biol. Chem. 284:49 (2009), 34342–34354.
41. [41] Kenig, S., Alonso, M.B., Mueller, M.M., Lah, T.T., Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett. 289:1 (2010), 53–61.
42. [42] Kang, T.W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479:7374 (2011), 547–551.
43. [43] Wu, A., Wei, J., Kong, L.Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., Heimberger, A.B., Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-oncol. 12:11 (2010), 1113–1125.
44. [44] Nijaguna, M.B., Patil, V., Urbach, S., Shwetha, S.D., Sravani, K., Hegde, A.S., Chandramouli, B.A., Arivazhagan, A., Marin, P., Santosh, V., Somasundaram, K., Glioblastoma-derived Macrophage Colony Stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-Binding Protein 1 (IGFBP1) to Promote Angiogenesis. J. Biol. Chem. 290:38 (2015), 23401–23415.
45. [45] Sielska, M., Przanowski, P., Wylot, B., Gabrusiewicz, K., Maleszewska, M., Kijewska, M., Zawadzka, M., Kucharska, J., Vinnakota, K., Kettenmann, H., Kotulska, K., Grajkowska, W., et al. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. J. Pathol. 230:3 (2013), 310–321.
46. [46] Bacher, M., Schrader, J., Thompson, N., Kuschela, K., Gemsa, D., Waeber, G., Schlegel, J., Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am. J. Pathol. 162:1 (2003), 11–17.
47. [47] Munaut, C., Boniver, J., Foidart, J.M., Deprez, M., Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol. Appl. Neurobiol. 28:6 (2002), 452–460.
48. [48] Beswick, E.J., Reyes, V.E., Macrophage migratory inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor. Infect. Immun. 76 (2008), 3233–3240.
49. [49] Kitange, G.J., Carlson, B.L., Schroeder, M.A., Decker, P.A., Morlan, B.W., Wu, W., Ballman, K.V., Giannini, C., Sarkaria, J.N., Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance. J. Neuro-oncol. 100:2 (2010), 177–186.
50. [50] Zeiner, P.S., Preusse, C., Blank, A.E., Zachskorn, C., Baumgarten, P., Caspary, L., Braczynski, A.K., Weissenberger, J., Bratzke, H., Reiß, S., Pennartz, S., Winkelmann, R., et al. MIF Receptor CD74 is restricted to microglia/macrophages, associated with a M1-polarized immune milieu and prolonged patient survival in gliomas. Brain Pathol. 25:4 (2015), 491–504.
51. [51] Szulzewsky, F., Pelz, A., Feng, X., Synowitz, M., Markovic, D., Langmann, T., Holtman, I.R., Wang, X., Eggen, B.J., Boddeke, H.W., Hambardzumyan, D., Wolf, S.A., et al. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS One, 10(2), 2015, e0116644.
52. [52] Kim, W.K., Alvarez, X., Fisher, J., Bronfin, B., Westmoreland, S., McLaurin, J., Williams, K., CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am. J. Pathol. 168:3 (2006), 822–834.
53. [53] Murdoch, C., Lewis, C.E., Macrophage migration and gene expression in response to tumor hypoxia. Int. J. Cancer 117:5 (2005), 701–708.
54. [54] Imtiyaz, H.Z., Williams, E.P., Hickey, M.M., Patel, S.A., Durham, A.C., Yuan, L.J., Hammond, R., Gimotty, P.A., Keith, B., Simon, M.C., Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest. 120:8 (2010), 2699–2714.
55. [55] Watters, J.J., Schartner, J.M., Badie, B., Microglia function in brain tumors. J. Neurosci. Res. 81 (2005), 447–455.
56. [56] He, L., Marneros, A.G., Doxyxycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization. J. Biol. Chem. 289:12 (2014), 8019–8028.
57. [57] Suomalainen, K., Sorsa, T., Golub, L.M., Ramamurthy, N., Lee, H.M., Uitto, V.J., Saari, H., Konttinen, Y.T., Specificity of the anticollagenase action of tetracyclines. Relevance to their anti-inflammatory potential. Antimicrob. Agents Chemother. 36 (1992), 227–229.
58. [58] Fainaru, O., Adini, I., Benny, O., Bazinet, L., Pravda, E., D'Amato, R., Folkman, J., Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J. 22 (2008), 3728–3735.
59. [59] Pyonteck, S.M., Akkari, L., Schuhmacher, A.J., Bowman, R.L., Sevenich, L., Quail, D.F., Olson, O.C., Quick, M.L., Huse, J.T., Teijeiro, V., Setty, M., Leslie, C.S., et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19:10 (2013), 1264–1272.
60. [60] Fujiwara, Y., Komohara, Y., Ikeda, T., Takeya, M., Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer Sci. 102:1 (2011), 206–211.
61. [61] Fujiwara, Y., Komohara, Y., Kudo, R., Tsurushima, K., Ohnishi, K., Ikeda, T., Takeya, M., Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncol. Rep. 26:6 (2011), 1533–1537.
62. [62] van Rooij, E., Kauppinen, S., Development of microRNA therapeutics is coming of age. EMBO Mol. Med. 6:7 (2014), 851–864.
63. [63] Anand, S., Coussens, L.M., Manipulating microRNAs to regulate macrophage polarization in gliomas. J. Natl. Cancer Inst., 106(8), 2014, dju230.
64. [64] Xu, S., Wei, J., Wang, F., Kong, L.Y., Ling, X.Y., Nduom, E., Gabrusiewicz, K., Doucette, T., Yang, Y., Yaghi, N.K., Fajt, V., Levine, J.M., et al. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J. Natl. Cancer Inst., 106(8), 2014, dju162.
65. [65] Chanmee, T., Ontong, P., Konno, K., Itano, N., Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel) 6:3 (2014), 1670–1690.
66. [66] Yi, L., Xiao, H., Xu, M., Ye, X., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., Feng, H., Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. Neuroimmunol. 232:1–2 (2011), 75–82.
67. [67] Gilbert, M.R., Dignam, J.J., Armstrong, T.S., Wefel, J.S., Blumenthal, D.T., Vogelbaum, M.A., Colman, H., Chakravarti, A., Pugh, S., Won, M., Jeraj, R., Brown, P.D., et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N. Engl. J. Med. 370:8 (2014), 699–708.
68. [68] Brooks, M.D., Sengupta, R., Snyder, S.C., Rubin, J.B., Hitting them where they live: targeting the glioblastoma perivascular stem cell niche. Curr. Pathobiol. Rep. 1:2 (2013), 101–110.
69. [69] Suryadevara, C.M., Verla, T., Sanchez-Perez, L., Reap, E.A., Choi, B.D., Fecci, P.E., Sampson, J.H., Immunotherapy for malignant glioma. Surg. Neurol. Int. 6:Suppl. 1 (2015), S68–S77.